BBLG FY 2020 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$825,014

Net Income

-$2M

EPS (Diluted)

$-35.68

Cash Flow

Operating Cash Flow

-$426,933

Free Cash Flow

-$426,933

Stock-Based Comp.

$60,000

Balance Sheet

Total Assets

$0

Total Liabilities

$14M

Stockholders' Equity

-$14M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$50	+100.0%
Operating Income	-$825,014	-$2M	+66.3%
Net Income	-$2M	-$3M	+46.7%